PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Titan Medical Inc. (TMD.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA88830X8199

CUSIP

88830X819

Sector

Healthcare

Highlights

Market Cap

CA$128.30M

EPS (TTM)

-CA$1.73

EBITDA (TTM)

-CA$1.76M

Year Range

CA$0.05 - CA$1.25

Target Price

CA$10.29

Short %

0.03%

Short Ratio

0.59

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in Titan Medical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13
2,127.45%
5.38%
TMD.TO (Titan Medical Inc.)
Benchmark (^GSPC)

Returns By Period


TMD.TO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of TMD.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202412.50%-5.56%-11.76%-20.00%-8.33%-9.09%5.00%14.29%-16.67%1,306.25%
202333.33%-76.25%-36.84%27.78%-6.52%-25.58%12.50%-5.56%-11.76%-10.00%-40.74%-0.00%-91.11%
2022-8.54%-1.33%-9.46%-16.42%10.71%6.45%6.06%-10.00%-1.59%0.00%4.84%38.46%9.76%
202147.93%-14.33%-23.27%-5.21%16.00%-9.48%0.48%-6.16%-3.54%4.71%-55.00%-8.89%-62.21%
2020-6.15%-18.03%-28.00%12.50%-11.11%219.44%6.09%-13.11%-9.43%-2.08%85.11%24.71%233.85%
2019185.21%7.05%-27.52%5.08%-12.47%-10.47%-15.26%9.96%-51.22%-56.43%40.98%-24.42%-61.54%
201813.33%-5.88%-32.50%-5.56%-3.92%0.00%-47.48%-31.61%4.17%-6.91%2.34%-35.50%-84.98%
201756.25%-7.00%-24.73%28.57%-21.67%-60.28%-1.79%5.45%134.49%25.00%-4.71%-7.41%17.19%
201625.00%-38.46%6.25%4.71%-12.36%11.54%-2.30%-22.35%-46.21%43.66%-19.61%-21.95%-69.23%
201529.29%-0.00%0.55%-13.74%7.64%-3.55%-3.07%-5.06%-9.33%-3.68%-19.08%-1.89%-25.71%
201483.16%-21.26%59.12%-18.35%1.12%41.67%-7.06%2.53%0.41%-7.79%-36.44%-2.10%47.37%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 89, TMD.TO is among the top 11% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TMD.TO is 8989
Overall Rank
The Sharpe Ratio Rank of TMD.TO is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of TMD.TO is 100100
Sortino Ratio Rank
The Omega Ratio Rank of TMD.TO is 100100
Omega Ratio Rank
The Calmar Ratio Rank of TMD.TO is 9999
Calmar Ratio Rank
The Martin Ratio Rank of TMD.TO is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Titan Medical Inc. (TMD.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
TMD.TO
^GSPC

There is not enough data available to calculate the Sharpe ratio for Titan Medical Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13
0.30
3.10
TMD.TO (Titan Medical Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Titan Medical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13
-98.58%
-0.32%
TMD.TO (Titan Medical Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Titan Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Titan Medical Inc. was 99.94%, occurring on Oct 10, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.94%Jul 4, 20142578Oct 10, 2024
-83.55%May 25, 2011587Sep 24, 2013115Mar 11, 2014702
-80%Jul 31, 2008190May 4, 2009323Aug 17, 2010513
-60%Oct 21, 2010102Mar 17, 201146May 24, 2011148
-35.25%Apr 8, 201431May 22, 201429Jul 3, 201460

Volatility

Volatility Chart

The current Titan Medical Inc. volatility is 318.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%Aug 25SeptemberSep 08Sep 15Sep 22Sep 29Oct 06Oct 13
318.69%
3.18%
TMD.TO (Titan Medical Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Titan Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Titan Medical Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab